The Children's Hospital at Montefiore Ranks in the Top-10 and Top-25 Nationwide for Kidney Care, Neurology and Neurosurgery Bronx, NY (June 7, 2010) - U.S. News & World Report announced its 2010-2011 edition of Best Children's Hospitals this week. The Children's Hospital at Montefiore (CHAM) was nationally recognized for its superior care in the kidney, neurology and neurosurgery specialties. CHAM ranked eighth in the U.S. for its advanced kidney program and twenty-second nationwide for its expertise in neurology and neurosurgery.
CHAM is a state-of-the-art comprehensive hospital serving more than 400,000 children in the Bronx, Westchester County and across the globe. With its unique integration of architecture, technology, education and inspiration, the hospital offers a family-centered approach to specialty pediatric care that it is among the finest in the nation.
"We are honored to be recognized as a national leader. Every day I get to observe the unique talent our doctors, nurses and staff have with children; for our talent and our organization to be ranked amongst the very best in the nation is a wonderful milestone and a really proud moment," said the Physician-in-Chief of The Children's Hospital at Montefiore, Philip O. Ozuah, M.D., Ph.D., and University Chairman, Albert Einstein College of Medicine
CHAM also ranked as one of "America's Best Children's Hospitals" in U.S. News & World Report in the 2008 and 2009 editions, making this the third consecutive year for the hospital to receive national recognition for its excellence.
###
For the News Media
View the latest media coverage, stories featuring our clinical experts, news releases, archives and background information about Montefiore.
Our Office of Public Relations is on call 24/7 to respond to media inquiries and requests for medical experts. Call 718-920-4011 or view our staff directory.

Chairman, Radiation Oncology
Montefiore is establishing new standards in radiation treatment for many cancers. For example, to treat lung cancer we use Image-Guided Intensity Modulated Radiation Therapy (IGRT), which allows unprecedented targeting of a lung tumor without harming surrounding tissue – even when the lungs move as the patient breathes.
